Cart
sales@molnova.com
JAK1-IN-31
CAS No. 1315498-72-6
JAK1-IN-31( —— )
Catalog No. M11278 CAS No. 1315498-72-6
JAK1-IN-31 is a potent and selective JAK1 inhibitor with Ki of 1.9 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJAK1-IN-31
-
NoteResearch use only, not for human use.
-
Brief DescriptionJAK1-IN-31 is a potent and selective JAK1 inhibitor with Ki of 1.9 nM.
-
DescriptionJAK1-IN-31 is a potent and selective JAK1 inhibitor with Ki of 1.9 nM, less potent for JAK3 (Ki=280 nM) and Tyk2 (Ki=12 nM) and no inhibition on hERG and CYP3A4 (IC50>10 uM); exhibits favorable oral bioavailability across a range of preclinical species and robust efficacy in a rat CIA model.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1315498-72-6
-
Formula Weight449.529
-
Molecular FormulaC23H23N5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Nametrans-4-(2-((R)-1-Hydroxyethyl)-6-(phenylsulfonyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexanecarbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zak M, et al. J Med Chem. 2013 Jun 13;56(11):4764-85.
molnova catalog
related products
-
Izencitinib
Izencitinib (JNJ-8398) is an orally active and gut-selective JAK inhibitor with potential anti-inflammatory activity for the study of ulcerative colitis and Crohn;s disease.
-
JAK-IN-21
JAK-IN-21 is a selective and potent JAK inhibitor that inhibits JAK1, JAK2, J2V617F and TYK2 with IC50 values of 1.73, 2.04, 109 and 62.9 nM, respectively.
-
Ruxolitinib
A potent, selective, orally active JAK1/JAK2 inhibitor with IC50 of 3.3/2.8 nM, respectively.
